Last week was a good week for global stocks. The MSCI World Index has gained about 4% for the week, tracking Wall Street with the major US indexes on track to begin a two-month losing streak in October. Markets will head towards the Federal Reserve meeting. US this week for signals that the central bank may pause rate hikes in the near future. Of the MSCI World stocks, 23 stocks have weekly gains of more than 15%, with seven stocks up more than 20%, as of the October 28 close. Here are eight stocks that investors have seen. Analysts see significant gains: In the name of America, several healthcare and pharmaceutical stocks have made the list, including Moderna, Centene and Teladoc Health. Teladoc jumped 23% last week, but only 15% of analysts rate the stock a buy. Analysts say the stock is up 13% on average, according to FactSet. Moderna, on the other hand, posted an average gain of 40%, according to analysts of the stock. More than 60% of analysts including Centene rate it buy and it has an average gain of 18%, according to FactSet data. It was up 16% last week. Japanese electronics company Ibiden was up more than 20% last week, and analysts think it’s up 23% on average. Over 90% of analysts rate this stock as a buy. Last week, the company increased its earnings per share guidance for the current fiscal year, from 301 Japanese yen ($2.03) to 344 yen, according to FactSet. Shares of US energy technology company Enphase Energy rose 21% last week, though analysts expect it to rise only 3% from here. The company beat profit and sales expectations when it reported third-quarter earnings last week, and earlier this month Goldman Sachs reiterated Enphase as a buying opportunity, saying “demand continues to be strong.” in the US and Europe will help stocks grow better. Another major global gainer was Australian gold miner Evolution Mining, up 15%. Analysts put an average gain of nearly 30%. Gold prices have mostly fallen this year, but they spiked last week as the US dollar fell. – Sarah Min of CNBC contributed to this report.